跳到正文
cccskills
免费在 GitHub 公开

es-cushing-treatment-goals-overt-cs

This skill defines the treatment goals for patients with overt Cushing's syndrome, focusing on normalizing cortisol levels or action to eliminate symptoms and treat comorbidities. Use when a clinician asks about treatment objectives for a newly diagnosed overt Cushing's syndrome patient; triggers include "overt CS," "treatment goals for overt Cushing's," and "normalize cortisol in overt CS."

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL
查看安装方法

包含的文件（1）

  • SKILL.md2.8 KB

SKILL.md（原文）

安装前可以查看交给 AI 代理的指令内容。

Treatment Goals for Overt Cushing's Syndrome

STEP 1 — Gather Information

Confirm diagnosis of overt Cushing's syndrome via clinical features (e.g., weight gain, hypertension, diabetes, skin changes) and biochemical tests (24‑h UFC > upper limit of normal, late‑night salivary cortisol > normal, or abnormal dexamethasone suppression test). Assess baseline comorbidities (hypertension, diabetes, dyslipidemia, osteoporosis, psychiatric symptoms) and current medications.

STEP 2 — Rule In / Rule Out

Rule in overt CS if biochemical hypercortisolism is present with specific signs/symptoms; rule out if only borderline biochemical abnormality of the HPA axis without any clinical manifestations of CS, as treatment is not recommended in that setting.

STEP 3 — Classify or Stratify

Classify postoperative or pretreatment cortisol status as hypercortisolemic (persistent elevated UFC or late‑night cortisol), eucortisolism (normal cortisol), or hypocortisolemic (low cortisol with symptoms of adrenal insufficiency). Persistent hypercortisolism after initial therapy indicates need for additional intervention.

STEP 4 — Decide

If hypercortisolism persists, initiate additional treatments (medical therapy, bilateral adrenalectomy, repeat transsphenoidal surgery, or radiation) aimed at normalizing cortisol; if eucortisolism is achieved, maintain cortisol normalization, treat comorbidities, and schedule lifelong surveillance for recurrence.

Clinical Guardrails / Mimics / Pitfalls

Do not treat based solely on borderline biochemical abnormalities without clinical signs; avoid overtreatment that may cause iatrogenic adrenal insufficiency; monitor for glucocorticoid withdrawal symptoms after surgery; address cortisol‑dependent comorbidities aggressively even when cortisol is normalized.

Concrete Clinical Example

A 48‑year‑man presents with progressive weight gain, new‑onset hypertension, and uncontrolled diabetes; 24‑h UFC is 6× ULN and late‑night salivary cortisol is elevated. Diagnosis of overt corticotropin‑secreting pituitary adenoma is confirmed. Treatment goal: normalize cortisol via transsphenoidal surgery, control hypertension and diabetes with adjunctive meds, and monitor postoperative cortisol and symptoms for remission.

Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., 2015, DOI:10.1210/jc.2015-1818

评价

还没有评价。欢迎分享你的使用感受。

评论

无需登录即可发表。欢迎分享使用感受、提问，或说明在哪些环境下无法运行。

还没有评论。来写第一条吧。

提交后会立即公开。请勿填写邮箱、电话等个人信息。URL 最多 2 个。

0 / 1000 字

此表单受 reCAPTCHA 保护，适用 Google 的隐私权政策和服务条款。

同一仓库的技能

780g-pump-adjustment

免费

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-acth-stim-test-interpretation

免费

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-adrenal-crisis-treatment

免费

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-aed-ai-education

免费

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-aed-lt4-monitoring

免费

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-cortisol-cutoff-ai-diagnosis

免费

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

查看 dromlakhani 的全部技能

报告此技能的问题